Correlation between specific antibody response to wild-type BNT162b2 booster and the risk of breakthrough infection with omicron variants: Impact of household exposure in hospital healthcare workers

被引:0
作者
Tani, Naoki [1 ]
Ikematsu, Hideyuki [2 ]
Goto, Takeyuki [1 ]
Kondo, Satoko [3 ]
Gondo, Kei [4 ]
Fujiyoshi, Naoko [5 ]
Minami, Junya [5 ]
Harada, Yukiko [5 ]
Nagano, Sukehisa [6 ]
Horiuchi, Takahiko [7 ]
Kuwano, Hiroyuki [7 ]
Akashi, Koichi [1 ]
Shimono, Nobuyuki [8 ]
Chong, Yong [1 ,9 ]
机构
[1] Kyushu Univ, Med & Biosyst Sci, Grad Sch Med Sci, Fukuoka 8128582, Japan
[2] Ric Clin Co, Fukuoka 8120013, Japan
[3] Fukuoka City Hosp, Dept Nursing, Fukuoka 8120046, Japan
[4] Fukuoka City Hosp, Clin Lab, Fukuoka 8120046, Japan
[5] Fukuoka City Hosp, Dept Infect Dis, Fukuoka 8120046, Japan
[6] Fukuoka City Hosp, Dept Neurol, Fukuoka 8120046, Japan
[7] Fukuoka City Hosp, Fukuoka 8120046, Japan
[8] Kyushu Univ Hosp, Ctr Study Global Infect, Fukuoka 8128582, Japan
[9] Kyushu Univ, Grad Sch Med Sci, Med & Biosyst Sci, 3-1-1 Maidashi, Fukuoka 8128582, Japan
关键词
SARS-CoV-2; Vaccine; Antibody; Breakthrough infection; Close contact; Omicron variant;
D O I
10.1016/j.vaccine.2023.09.051
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: The emergence of omicron variants exhibiting antigenic changes has led to an increase in breakthrough infection among individuals with a wild-type SARS-CoV-2 vaccine booster. The correlation between post-booster spike-specific antibodies and omicron infection risk remains unclear. Methods: This prospective cohort study included SARS-CoV-2-naive healthcare workers with three-dose BNT162b2. Post-booster spike-specific IgG and interferon-gamma levels were measured. Breakthrough infection was documented during a 10-month omicron-predominant period. Household and healthcare contacts were followed to identify subsequent infections. The IgG titers were additionally measured at the end of follow-up, and the titers at exposure were estimated from the two-point titers. Results: Of 333 participants, 89 developed infection, of whom 37 (41.6 %) were household contacts. Kaplan-Meier curves indicated that higher IgG titers were significantly correlated with lower cumulative infection incidence (p = 0.029), whereas the interferon-gamma levels were not (p = 0.926). Multivariate Cox analysis showed that increasing IgG titers were associated with a reduced hazard ratio (HR) of 0.26 (95% CI, 0.12-0.55). Household exposure posed a greater infection risk than healthcare exposure (HRs, 11.24 [6.88-18.40] vs. 2.82 [1.37-5.44]). The difference in geometric mean IgG titers of infected and uninfected participants was significant among household contacts (20,244 AU/mL vs. 13,842 AU/mL, p = 0.031). Estimation of IgG titers at exposure showed a significantly higher infection incidence in those exposed with titers of <3,000 AU/mL than in those with higher titers (79.2 % vs. 32.3 %, p < 0.001). Conclusions: Spike-specific antibodies induced by a wild-type SARS-CoV-2 vaccine booster are suggested to be effective in protecting against omicron infection. Household exposure would be a significant source of infection for hospital healthcare workers.
引用
收藏
页码:6672 / 6678
页数:7
相关论文
共 33 条
  • [1] Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants
    Accorsi, Emma K.
    Britton, Amadea
    Fleming-Dutra, Katherine E.
    Smith, Zachary R.
    Shang, Nong
    Derado, Gordana
    Miller, Joseph
    Schrag, Stephanie J.
    Verani, Jennifer R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (07): : 639 - 651
  • [2] SARS-CoV-2 antibodies and breakthrough infections in the Virus Watch cohort
    Aldridge, Robert W.
    Yavlinsky, Alexei
    Nguyen, Vincent
    Eyre, Max T.
    Shrotri, Madhumita
    Navaratnam, Annalan M. D.
    Beale, Sarah
    Braithwaite, Isobel
    Byrne, Thomas
    Kovar, Jana
    Fragaszy, Ellen
    Fong, Wing Lam Erica
    Geismar, Cyril
    Patel, Parth
    Rodger, Alison
    Johnson, Anne M.
    Hayward, Andrew
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)
  • [3] Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses
    Almendro-Vazquez, Patricia
    Chivite-Lacaba, Marta
    Utrero-Rico, Alberto
    Gonzalez-Cuadrado, Cecilia
    Laguna-Goya, Rocio
    Moreno-Batanero, Miguel
    Sanchez-Paz, Laura
    Luczkowiak, Joanna
    Labiod, Nuria
    Dolores Folgueira, Maria
    Delgado, Rafael
    Paz-Artal, Estela
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [4] Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes
    Buchan, Sarah A.
    Chung, Hannah
    Brown, Kevin A.
    Austin, Peter C.
    Fell, Deshayne B.
    Gubbay, Jonathan B.
    Nasreen, Sharifa
    Schwartz, Kevin L.
    Sundaram, Maria E.
    Tadrous, Mina
    Wilson, Kumanan
    Wilson, Sarah E.
    Kwong, Jeffrey C.
    [J]. JAMA NETWORK OPEN, 2022, 5 (09) : E2232760
  • [5] Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
    Feng, Shuo
    Phillips, Daniel J.
    White, Thomas
    Sayal, Homesh
    Aley, Parvinder K.
    Bibi, Sagida
    Dold, Christina
    Fuskova, Michelle
    Gilbert, Sarah C.
    Hirsch, Ian
    Humphries, Holly E.
    Jepson, Brett
    Kelly, Elizabeth J.
    Plested, Emma
    Shoemaker, Kathryn
    Thomas, Kelly M.
    Vekemans, Johan
    Villafana, Tonya L.
    Lambe, Teresa
    Pollard, Andrew J.
    Voysey, Merryn
    [J]. NATURE MEDICINE, 2021, 27 (11) : 2032 - +
  • [6] Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
    Gilbert, Peter B.
    Montefiori, David C.
    McDermott, Adrian
    Fong, Youyi
    Benkeser, David
    Deng, Weiping
    Zhou, Honghong
    Houchens, Christopher R.
    Martins, Karen
    Jayashankar, Lakshmi
    Castellino, Flora
    Flach, Britta
    Lin, Bob C.
    O'Connell, Sarah
    McDanal, Charlene
    Eaton, Amanda
    Sarzotti-Kelsoe, Marcella
    Lu, Yiwen
    Yu, Chenchen
    Borate, Bhavesh
    van der Laan, Lars W. P.
    Hejazi, Nima
    Huynh, Chuong
    Miller, Jacqueline
    El Sahly, Hana M.
    Baden, Lindsey R.
    Baron, Mira
    De la Cruz, Luis
    Gay, Cynthia
    Kalams, Spyros
    Kelley, Colleen F.
    Andrasik, Michele P.
    Kublin, James G.
    Corey, Lawrence
    Neuzil, Kathleen M.
    Carpp, Lindsay N.
    Pajon, Rolando
    Follmann, Dean
    Donis, Ruben O.
    Koup, Richard A.
    [J]. SCIENCE, 2022, 375 (6576) : 43 - +
  • [7] Durability of Immune Response After COVID-19 Booster Vaccination and Association With COVID-19 Omicron Infection
    Gilboa, Mayan
    Regev-Yochay, Gili
    Mandelboim, Michal
    Indenbaum, Victoria
    Asraf, Keren
    Fluss, Ronen
    Amit, Sharon
    Mendelson, Ella
    Doolman, Ram
    Afek, Arnon
    Freedman, Laurence S.
    Kreiss, Yitshak
    Lustig, Yaniv
    [J]. JAMA NETWORK OPEN, 2022, 5 (09) : E2231778
  • [8] Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection
    Goto, Takeyuki
    Tani, Naoki
    Ikematsu, Hideyuki
    Gondo, Kei
    Oishi, Ryo
    Minami, Junya
    Onozawa, Kyoko
    Kuwano, Hiroyuki
    Akashi, Koichi
    Shimono, Nobuyuki
    Chong, Yong
    [J]. PLOS ONE, 2022, 17 (07):
  • [9] Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster
    Kurhade, Chaitanya
    Zou, Jing
    Xia, Hongjie
    Liu, Mingru
    Chang, Hope C.
    Ren, Ping
    Xie, Xuping
    Shi, Pei-Yong
    [J]. NATURE MEDICINE, 2023, 29 (02) : 344 - 347
  • [10] Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
    Levin, Einav G.
    Lustig, Yaniv
    Cohen, Carmit
    Fluss, Ronen
    Indenbaum, Victoria
    Amit, Sharon
    Doolman, Ram
    Asraf, Keren
    Mendelson, Ella
    Ziv, Arnona
    Rubin, Carmit
    Freedman, Laurence
    Kreiss, Yitshak
    Regev-Yochay, Gili
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (24) : E84 - E84